Clinical trial
Evaluating Microdosing in Emergency Departments: A Randomized Controlled Trial Comparing the Effectiveness of Buprenorphine/Naloxone Microdosing vs. Standard Dosing (EMED Study)
NCT04893525 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluating Microdosing in Emergency Departments: A Randomized Controlled Trial Comparing the Effectiveness of Buprenorphine/Naloxone Microdosing vs. Standard Dosing (EMED Study)
- Lead sponsor
- University of British Columbia
- Phase
- Phase 2/3
- Overall status
- Recruiting
- Start date
- July 23, 2021
- Completion date
- June 30, 2028
- Enrollment
- 658 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
opioid-use disorder